Clinical trial • Phase I • Oncology

KQB198 for Advanced solid malignancies

Phase I trial of KQB198 for Advanced solid malignancies. 50 participants.

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Advanced solid malignancies
Trial Stage
Phase I

Key dates

Initial CTIS Submission Date
13-05-2024
First CTIS Authorization Date
29-08-2024

Trial design

Phase I trial across 25 sites in Italy, Spain, France.

Target Sample Size
50

Eligibility

Recruits 50 Vulnerable population selected; no further details on consent or assent handling available in source..

Vulnerable Population
Vulnerable population selected; no further details on consent or assent handling available in source.

Recruitment

Planned Sample Size
50
Recruitment Window Months
35
Consent Approach
No information on consent or assent available in source.

Geography

Total Number Of Sites
25
Total Number Of Participants
112

Italy

Earliest CTIS Part Ii Submission Date
06-08-2024
Latest Decision Or Authorization Date
05-09-2025
Processing Time Days
395
Number Of Sites
8
Number Of Participants
30

Sites

Site Name
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Department Name
U.O.C. Phase 1
Contact Person Name
Gennaro Daniele
Site Name
ASST Grande Ospedale Metropolitano Niguarda
Department Name
SC Oncologia Falck, Niguarda Cancer Center
Contact Person Name
Giulio Cerea
Site Name
Fondazione IRCCS Policlinico San Matteo
Department Name
S.C. Oncologia
Contact Person Name
Francesco Agustoni
Contact Person Email
f.agustoni@smatteo.pv.it
Site Name
Centro Di Riferimento Oncologico Di Aviano
Department Name
S.O.C. Oncologia medica e dei tumori immuno-correlati
Contact Person Name
Alessandra Bearz
Contact Person Email
abearz@cro.it
Site Name
Ospedale San Raffaele S.r.l.
Department Name
U.O. Oncologia Medica
Contact Person Name
Gianluca Del Conte
Contact Person Email
delconte.gianluca@hsr.it
Site Name
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Department Name
Ricerca Traslazionale a Servizio dei Percorsi Oncologici
Contact Person Name
Adriano Gravina
Contact Person Email
a.gravina@istitutotumori.na.it
Site Name
Istituto Europeo Di Oncologia S.r.l.
Department Name
Divisione di Sviluppo di Nuovi Farmaci per Terapie Innovative
Contact Person Name
Giuseppe Curigliano
Contact Person Email
giuseppe.curigliano@ieo.it
Site Name
Azienda Unita Sanitaria Locale Della Romagna
Department Name
U.O. Oncologia, Dipartimento Onco-Ematologico
Contact Person Name
Manolo D'Arcangelo

Spain

Earliest CTIS Part Ii Submission Date
24-06-2024
Latest Decision Or Authorization Date
12-08-2025
Processing Time Days
414
Number Of Sites
10
Number Of Participants
40

Sites

Site Name
Hospital Universitario Hm Sanchinarro
Department Name
Oncology
Contact Person Name
Ramon Yarza
Contact Person Email
Ramon.Yarza@startmadrid.com
Site Name
Clinica Universidad De Navarra
Department Name
Oncology
Contact Person Name
Anna Vilalta Lacarra
Contact Person Email
avilaltal@unav.es
Site Name
Hospital Universitari Vall D Hebron
Department Name
Oncology
Contact Person Name
Nuria Pardo Aranda
Contact Person Email
npardo@vhio.net
Site Name
Hospital Quironsalud Barcelona
Department Name
Oncology
Contact Person Name
Elena Garralda Cabanas
Contact Person Email
e.garralda@nextoncology.eu
Site Name
Hospital Hm Nou Delfos
Department Name
Oncology
Contact Person Name
Tatiana Hernandez Guerrero
Site Name
Hospital Quironsalud Malaga
Department Name
Oncology
Contact Person Name
Manuel Cobo Dols
Contact Person Email
manuelcobodols@yahoo.es
Site Name
Hospital Universitario Quironsalud Madrid
Department Name
Oncology
Contact Person Name
Valentina Boni
Contact Person Email
vboni@nextoncology.eu
Site Name
Hospital Universitario Fundacion Jimenez Diaz
Department Name
Oncology
Contact Person Name
Victor Moreno Garcia
Contact Person Email
victor.moreno@startmadrid.com
Site Name
Hospital Universitari Dexeus Grupo Quironsalud
Department Name
Oncology
Contact Person Name
Andres Aguilar Hernandez
Contact Person Email
aaguilar@oncorosell.com
Site Name
Hospital Universitario Ramon Y Cajal
Department Name
Oncology
Contact Person Name
Pilar Garrido Lopez
Contact Person Email
pilargarridol@gmail.com

France

Earliest CTIS Part Ii Submission Date
04-07-2024
Latest Decision Or Authorization Date
09-01-2026
Processing Time Days
554
Number Of Sites
7
Number Of Participants
42

Sites

Site Name
Oncopole Claudius Regaud
Department Name
Oncologie Médical
Contact Person Name
Audrey RABEAU
Contact Person Email
rabeau.audrey@iuct-oncopole.fr
Site Name
Centre Hospitalier Universitaire De Bordeaux
Department Name
Oncologie Médical
Contact Person Name
Amaury DASTE
Contact Person Email
amaury.daste@chu-bordeaux.fr
Site Name
Centre Hospitalier Universitaire De Nantes
Department Name
Oncologie thoracique
Contact Person Name
Jeanne CHEN
Contact Person Email
jeanne.chen@chu-nantes.fr
Site Name
Institut De Cancerologie De L Ouest
Department Name
Oncologie Médical
Contact Person Name
Judith Raimbourg
Site Name
Centre Leon Berard
Department Name
Oncologie Médical
Contact Person Name
Maurice PEROL
Site Name
Centre Hospitalier Universitaire Grenoble Alpes
Department Name
Oncologie thoracique
Contact Person Name
Denis MORO-SIBILOT
Contact Person Email
DMoro-Sibilot@chu-grenoble.fr
Site Name
Institut Paoli Calmettes
Department Name
Oncologie Médical
Contact Person Name
Cecile VICIER
Contact Person Email
VICIERC@ipc.unicancer.fr

Sponsor

Primary sponsor

Full Name
Kumquat Biosciences Inc.
Organisation Type
Laboratory/Research/Testing facility
Country Of Registered Address
United States

Investigational products

Investigational Product Name
KQB198
Combination Treatment
Yes

Related trials

Other published trials that may interest you.